Skip to main content
Universe Pharmaceuticals INC logo

Universe Pharmaceuticals INC — Investor Relations & Filings

Ticker · UPC ISIN · KYG9442G1047 US Manufacturing
Open in API
Filings indexed 99 across all filing types
Latest filing 2021-03-17 Regulatory Filings
Country US United States of America
Listing US UPC

About Universe Pharmaceuticals INC

http://www.universe-pharmacy.com/

Universe Pharmaceuticals INC is a pharmaceutical company specializing in the manufacturing, marketing, sales, and distribution of traditional Chinese medicine (TCM) derivative products. Through its subsidiaries, the company's product portfolio also includes biomedical drugs, medical instruments, Traditional Chinese Medicine Pieces (TCMPs), and dietary supplements.

Recent filings

Filing Released Lang Actions
Regulatory Filings 2021
Regulatory Filings Classification · 95% confidence The document is a letter addressed to the SEC Division of Corporation Finance regarding a Registration Statement on Form F-1/A. It requests acceleration of the effective date of the registration statement under the Securities Act of 1933. The content is related to the regulatory process of securities registration and does not contain financial statements, earnings data, or detailed report content. It is a regulatory communication about the filing process rather than a financial report or announcement of results. The document length is short (1514 characters), and it is a formal regulatory filing related to securities registration. Therefore, it fits best under Regulatory Filings (RNS).
2021-03-17 English
Regulatory Filings 2021
Regulatory Filings Classification · 95% confidence The document is a letter from Universe Pharmaceuticals INC to the SEC requesting acceleration of effectiveness for a Registration Statement on Form F-1. This is a regulatory filing related to securities registration and does not contain financial statements or detailed financial data. It is a formal communication about the status of a filing rather than the filing itself. The document length is short (1064 characters), and it is a correspondence letter, not a report or announcement of financial results. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for such communications.
2021-03-17 English
FORM 8-A12B
Regulatory Filings Classification · 100% confidence The document is a Form 8-A12B filed with the SEC for registration of certain classes of securities pursuant to Section 12(b) or 12(g) of the Securities Exchange Act of 1934. It describes the registration of ordinary shares of Universe Pharmaceuticals INC on the Nasdaq Stock Market. The document includes no financial statements or detailed financial data, but is a regulatory filing to register securities. It is not an annual report, earnings release, or any other financial report type. It is a regulatory announcement related to securities registration, fitting best under Regulatory Filings (RNS). The document length is short (3375 characters) and it is a formal SEC filing form, confirming the classification as RNS.
2021-03-17 English
Regulatory Filings 2021
Regulatory Filings Classification · 95% confidence The document is a detailed response letter from Universe Pharmaceuticals Inc. to the SEC staff regarding comments on their Registration Statement on Form F-1. It discusses amendments to the registration statement, internal control weaknesses, financial statement preparation under US GAAP, material audit adjustments, and detailed financial disclosures. The document is not a full financial report but a regulatory correspondence addressing SEC comments on a registration filing. It references Form F-1 amendments and includes detailed explanations and revisions to disclosures in the registration statement. This type of document is best classified as a Regulatory Filing (RNS) because it is a formal response to SEC comments on a registration statement, not the registration statement itself or a financial report like an annual or quarterly report.
2021-03-10 English
AMENDMENT NO. 4 TO FORM F-1
Capital/Financing Update Classification · 100% confidence The document is an Amendment No. 4 to Form F-1 Registration Statement filed with the SEC, which is a registration statement for an initial public offering (IPO). It includes detailed information about the securities being registered, the offering price, underwriting arrangements, and other disclosures typical of a registration statement under the Securities Act of 1933. This is not a financial report, earnings release, or management discussion, but a regulatory filing related to capital raising and securities registration. Therefore, the appropriate classification is Capital/Financing Update (CAP). The document length and content confirm it is not a brief announcement or a report publication notice, but a substantive filing related to capital raising.
2021-03-10 English
Regulatory Filings 2021
Regulatory Filings
2021-03-02 English

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.